Navigation Links
Go for Russia, Not China, Wine Experts Say

With domestic consumption of wine halved in France since the 1950s, the world's number one wine producer has turned to emerging market exports as its saviour. But while the Chinese and Indians have been feted at this year's Vinexpo wine trade show, the worlds largest, there are those attending the two-yearly event who warn against both in preference to Russia.

"The margins in China are not there. It is not ready to buy at the price point where wine producers will make money," said David Skalli, a Paris-based wine consultant with family vineyards in France, California and Italy. "You have to be there, but you won't make money for the next 10 years and it is very competitive."

In India, said Skalli, the market is growing by 30 percent, but from a tiny part of the population. "Per head consumption in India is about one teaspoon," he said, but the biggest barriers are duties, about 300 percent, and logistics. Duties are to come down to 150 percent by the end of the year, but distribution and wine understanding remain difficulties.

Local sommelier Magandeep Singh, who flew to Bordeaux from New Delhi for Vinexpo, agrees that the spirit is there, but the logistics are weak. "The question I am most often asked in India is 'where can I get good wine?'," he said, but the supply is just not there. "People want wine in India and they have money - my local BMW salesroom which opened in December is sold out for the next year, some people think nothing of spending 60,000 euros on a car you see. But if you can't get the wine it's no good." The problem, agreed Singh, are the laws, the taxes, the paperwork and the differences between those in the different states.

"At the moment 80 percent of the wine in India is sold by hotels in Bombay and Delhi." All this could change next year however with the opening of Wal-Mart, Carrefour and Tesco outlets in 2008. "And that is because India's next boom is retail," he said. "Even if you
'"/>




Page: 1 2 3

Related medicine news :

1. Fear of Dengue looms large in China, as Mosquitoes Make Most of Sunshine!
2. China, France to Jointly Develop Traditional Chinese Medicines
3. Good carb, bad carb? Experts debate.
4. Spread Of Rocky Mountain Spotted Fever Is A Probability, Say Experts
5. Experts Recommend Preventive Measures For Avian Flu To Begin From Farms
6. Experts Insist That Neonatal Herpes Be Reported Regularly
7. Experts State Strategies To Increase Good Cholesterol
8. Cancer Can Recur Any Time, Experts Caution
9. Experts Building Bird Flu Warning System
10. Human Growth Hormone (HGH) - View of Experts
11. Experts urging artery screening in the UK
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: for Russia Not China Wine Experts Say

(Date:9/4/2008)... may be shortchanging their golden years by tappin...iversity of Illinois expert who has studied the fe..., More than three of every four Americans trim th...iming benefits early, a choice many might forego i... consequences, law professor Richard L. Kaplan say...
(Date:9/4/2008)...ncology contract research organization, has publis...uanced Approach to Get Into the Clinic Faster.&quo...al research scientist with 35 years of experience,...mmonly viewed as straightforward investigations ru...rue integration with preclinical, regulatory and c...
(Date:9/4/2008)...NORWICH, England and ONGAR, Ireland,Sept. 4 /PRNe...ofield Media,Europe Ltd, announced on the 29th Aug... publication from Silverdog Publishing., Health a... the iconic,Health and Safety at Work Act 1974 and.... It has been relied upon by blue-chip corporates,...
(Date:9/4/2008)...-FirstCall/ -- ULURU Inc. (Amex:,ULU) today announ...Weisel,Partners Healthcare Conference at 3:15 p.m....out ULURU Inc.:, ULURU Inc. is an emerging specia...ent of a portfolio of wound management, plastic su...nd consumers improved clinical,outcomes through co...
Breaking Medicine News(10 mins):Health News:New guide explores making the most of Social Security 2Health News:New guide explores making the most of Social Security 3Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 2Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 3Health News:Schofield Publishing Enters the Newsletter Market 2
...scinating areas of biology today, with new experim...about the potential applications of stem cells. Sc...rat // sperm cells to behave like embryonic stem c... to various cell lineages such as a nerve cell, bl...
...ence Livermore National Laboratory are studying th...derstand the mechanism of protein folding. The new...// how a protein is incorrectly folded which leads...ublished in the Journal Proceedings of the Nationa...
...'ll see that lots of middle-aged men are losing th...a bit, it turns out, reports AP. A British compan...und with hundreds more hairs than they had before,...n called hair cloning. An American outfit hopes to...
...the AIDS epidemic, South Africa's first Phase II H...p the International AIDS Vaccine Initiative (IAVI)... The trials will test the safety of "tgAAC09" is a... is based on HIV subtype C, the subtype of the vir...
Other Medicine News:Health News:Sperm stem cells could be an alternative to embryonic stem cells in future 2Health News:Scientists Seek New Ways To Grow Hair On Bald Pates 2Health News:Scientists Seek New Ways To Grow Hair On Bald Pates 3Health News:Scientists Seek New Ways To Grow Hair On Bald Pates 4Health News:Phase II trails of new HIV vaccine to be held in South Africa 2
(Date:9/3/2008)...G, Md., Sept. 3 /- Panacea Pharmaceut...atent Number 7,413,737 covering,antibodies against...AH), a,proprietary human cancer biomarker and ther... collaboration with the Massachusetts Institute of...wide rights to this patent,for development of huma...
(Date:9/3/2008)... Trial Reconfirms Strong Evidence Pycnogenol(R) Lo...ffect on Joints Following Cessation .... 3 /- According to the Center for,Di...on type of arthritis,is on the rise. A new study ...search, reveals Pycnogenol(R), bark extract from t...
(Date:9/2/2008)...ember 3 /-, - This Analysi...e Risk,of Stroke by 34% in Patients With Atrial Fi...eated by Antithrombotic Therapy, The results of a...dy,were presented today at the clinical trial upda...ongress 2008, in Munich, Germany. Previous results...
(Date:9/2/2008)...y Meets Primary Bone Mineral Density and Secondary... Company to Host Conference Call and Webcast Wedn...0 am ET / 5:30 am PT, SAN DIEGO, Sept. 2 /PRNewsw...sdaq: NBIX ) today announced positive safety and ...trial using its proprietary, orally-active,nonpept...
Breaking Medicine Technology:Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 2Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 3Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 4Study Shows Pine Bark Naturally Reduces Knee Osteoarthritis 2Study Shows Pine Bark Naturally Reduces Knee Osteoarthritis 3Study Shows Pine Bark Naturally Reduces Knee Osteoarthritis 4Further Analysis From ATHENA Study Showed That Multaq(R)(Dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 2Further Analysis From ATHENA Study Showed That Multaq(R)(Dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 3Further Analysis From ATHENA Study Showed That Multaq(R)(Dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 4Further Analysis From ATHENA Study Showed That Multaq(R)(Dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 5Neurocrine Biosciences Announces Successful Elagolix PETAL Study in Endometriosis 2Neurocrine Biosciences Announces Successful Elagolix PETAL Study in Endometriosis 3Neurocrine Biosciences Announces Successful Elagolix PETAL Study in Endometriosis 4Neurocrine Biosciences Announces Successful Elagolix PETAL Study in Endometriosis 5Neurocrine Biosciences Announces Successful Elagolix PETAL Study in Endometriosis 6Reflecting on the social implications of human genetics research past present and future 2780 1Reflecting on the social implications of human genetics research past present and future 2780 2Analysis Highlights Economic Contribution of Hospitals to Communities 16090 1Analysis Highlights Economic Contribution of Hospitals to Communities 16090 2Quest Diagnostics to Release First Quarter 2008 Financial Results and Conduct Quarterly Investor Conference Call 16088 1Quest Diagnostics to Release First Quarter 2008 Financial Results and Conduct Quarterly Investor Conference Call 16088 2VA Announces SGLI and VGLI Premium Reductions 16086 1VA Announces SGLI and VGLI Premium Reductions 16086 2
...nistration show potential for,new option to improv...07 /PRNewswire-FirstCall/ -- Millennium,Pharmaceut...sitive,data for VELCADE, the market-leading therap... received at least one prior therapy.,These data i...ous,(SC) administration of VELCADE, a new option u...
...llicular Lymphoma Reported,Today at ASCO Annual Me... GlaxoSmithKline plc,announced today long-term eff...eek course of frontline treatment with the BEXXAR(...31 Tositumomab) in,76 patients with newly diagnose.... This regimen was found to induce durable clinica...
Other Medicine Technology:New Data on Market-Leading Velcade (Bortezomib) for Injection,Further Strengthen Role in Previously Treated Multiple Myeloma 2New Data on Market-Leading Velcade (Bortezomib) for Injection,Further Strengthen Role in Previously Treated Multiple Myeloma 3New Data on Market-Leading Velcade (Bortezomib) for Injection,Further Strengthen Role in Previously Treated Multiple Myeloma 4New Data on Market-Leading Velcade (Bortezomib) for Injection,Further Strengthen Role in Previously Treated Multiple Myeloma 5New Data on Market-Leading Velcade (Bortezomib) for Injection,Further Strengthen Role in Previously Treated Multiple Myeloma 6New Data on Market-Leading Velcade (Bortezomib) for Injection,Further Strengthen Role in Previously Treated Multiple Myeloma 78-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 28-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 38-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 48-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 58-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 68-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 7
...xpensive of the series. It has the ability to phot... of the cornea. The model comes with a 9 high-reso... of a patients corneal endothelium, you simply ask...rest. The left side of the chin rest allows you to...
The simplest, most accurate Ortho-K lens fitting system ever!
...ogy (oprifocon A) Contact Lenses are rigid gas per...process that temporarily corrects nearsightedness ... and removes them in the morning. During the day, ...y reduced., ,The Euclid Systems Orthokeratology (o...
...ontact lenses used for corneal refractive therapy,...ss (myopia). The patient wears the lenses overnigh...uring the day, nearsightedness is corrected or gre...ct lenses apply slight pressure to the center of t...
Medicine Products: